BIOCON quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Biocon Ltd reported sales of ₹4,389 Cr, operating profit of ₹831 Cr (OPM 19%) and net profit of ₹57 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
BIOCON quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
3,821
4,417
3,942
4,296
4,173
4,517
4,336
4,389
YoY Sales growth
-3
13
15
20
9
2
10
2
Expenses
3,070
3,339
3,176
3,460
3,340
3,496
3,489
3,558
Operating Profit
752
1,078
766
835
834
1,020
847
831
OPM
20%
24%
19%
19%
20%
23%
20%
19%
Other Income
53
57
62
81
-176
-28
41
28
Interest
223
212
277
272
210
232
213
240
Depreciation
425
436
455
473
515
513
547
564
Profit before tax
156
487
97
171
-68
248
128
55
Tax
48%
6%
8%
22%
-24%
20%
-7%
-3%
Net Profit
81
459
89
133
-52
199
137
57
EPS in Rs
0.21
2.87
0.23
0.63
1.08
0.78
0.87
0.25
BIOCON profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
8,184
11,174
14,756
15,262
16,927
17,414
Sales growth
15
37
32
3
11
6
Expenses
6,391
8,762
11,540
12,008
13,456
13,883
Operating Profit
1,793
2,412
3,216
3,254
3,471
3,532
OPM
22%
22%
22%
21%
21%
20%
Other Income
72
18
853
1,217
-76
-135
Interest
68
419
974
897
990
895
Depreciation
814
1,113
1,569
1,687
1,957
2,140
Profit before tax
983
897
1,525
1,887
448
362
Tax
22%
28%
15%
24%
18%
-
Net Profit
772
643
1,298
1,429
369
340
EPS in Rs
5.4
3.85
8.52
8.44
2.38
2.98
Dividend Payout
9%
39%
6%
6%
21%
-
BIOCON balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
600
600
668
810
815
Reserves
19,183
21,044
26,135
33,221
34,028
Borrowings
16,277
18,362
16,536
15,434
15,698
Other Liabilities
19,693
18,534
19,421
13,943
14,739
Total Liabilities
55,753
58,540
62,760
63,409
65,280
Fixed Assets
30,644
31,963
37,262
36,486
39,689
CWIP
7,993
8,508
4,651
6,987
4,568
Investments
1,000
1,127
2,333
1,779
1,324
Other Assets
16,117
16,941
18,513
18,157
19,699
Total Assets
55,753
58,540
62,760
63,409
65,280
BIOCON cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
1,177
1,852
2,954
4,061
1,994
Cash from Investing Activity
-1,662
-14,260
-1,002
-203
-1,883
Cash from Financing Activity
242
13,049
-2,333
-1,854
-924
Net Cash Flow
-243
641
-380
2,004
-812
Free Cash Flow
-746
129
1,046
1,718
82
CFO/OP
80%
86%
101%
139%
64%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit